Obscure anaemia and hepatic dysfunction in Castleman's disease.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 1379229)

Published in Gut on January 01, 1991

Authors

I A Finnie, I T Gilmore

Articles cited by this

Obscure anaemia and hepatic dysfunction in Castleman's disease. Gut (1990) 1.42

Articles by these authors

Cigarette smoking and inflammatory bowel disease. Gastroenterology (1987) 2.04

Cost effectiveness of detecting Barrett's cancer. Gut (1996) 1.63

Alcohol abuse and the burden on the NHS--time for action. J R Coll Physicians Lond (2000) 1.44

The burden of alcohol misuse on an inner-city general hospital. QJM (2000) 1.31

Gastrointestinal manifestations of Addison's disease. Am J Gastroenterol (1989) 1.26

Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. J Clin Invest (1995) 1.22

A national training programme for gastroenterology and hepatology. Gut (1996) 1.14

Late bleeding after endoscopic sphincterotomy for bile duct calculi. BMJ (1991) 1.14

Transjugular liver biopsy. Br Med J (1977) 1.07

Paracetamol-induced acute pancreatitis. Br Med J (1977) 1.07

Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist. Aliment Pharmacol Ther (1990) 1.05

Plugged liver biopsy in patients with impaired coagulation. Dig Dis Sci (1989) 1.04

Experience with transjugular liver biopsy. Gut (1983) 1.04

Ultrasound diagnosis of bile duct calculi. Br Med J (Clin Res Ed) (1986) 0.97

The biliary and urinary metabolites of [3H]17 alpha-ethynylestradiol in women. Xenobiotica (1983) 0.97

TIPSS in the treatment of ectopic variceal bleeding. Hepatogastroenterology (2006) 0.96

Orocaecal transit time in health and in thyroid disease. Gut (1989) 0.95

Genetic polymorphism of cytochrome P4502E1 and risk of alcoholic liver disease in Caucasians. Pharmacogenetics (1995) 0.91

Half-life time or clearance of indocyanine green in patients with liver disease. Hepatogastroenterology (1982) 0.90

Cholecystokinin cholecystography, sonography, and scintigraphy: detection of chronic acalculous cholecystitis. AJR Am J Roentgenol (1982) 0.88

Plasma clearance of oral and intravenous cholic acid in subjects with and without chronic liver disease. Gut (1980) 0.88

Screening for occult gastrointestinal bleeding in hospital patients. J R Soc Med (1981) 0.88

Kinetics of 14C-glycocholic acid clearance in normal man and in patients with liver disease. Gut (1978) 0.87

Comparison between the cellobiose/mannitol and 51Cr-labelled ethylenediaminetetra-acetate absorption tests in the detection of coeliac disease. Clin Sci (Lond) (1988) 0.86

Secondary bile acid induced DNA damage in HT29 cells: are free radicals involved? Free Radic Res (1997) 0.85

High performance gel filtration using monodisperse highly cross-linked agarose as a one-step system for mucin purification. Biomed Chromatogr (1993) 0.85

Improved method of transvenous liver biopsy. Br Med J (1978) 0.84

Comparison of the Trucut and Surecut liver biopsy needles. J Clin Pathol (1982) 0.84

Altered drug metabolism and elevated serum bile acids in liver disease: a unified pharmacokinetic explanation. Gastroenterology (1980) 0.84

Pregnancy in Crigler-Najjar syndrome. Case report. Br J Obstet Gynaecol (1991) 0.84

Measurement of menadione-mediated DNA damage in human lymphocytes using the comet assay. Free Radic Res (1997) 0.83

HCV-associated liver cancer. Lancet (1995) 0.83

Effect of genotypes on the quantification of hepatitis C virus (HCV) RNA in clinical samples using the Amplicor HCV Monitor Test and the Quantiplex HCV RNA 2.0 assay (bDNA). J Med Virol (1998) 0.82

Reduction in toxicity of doxorubicin by liposomal entrapment. Lancet (1987) 0.82

Yersinia pseudotuberculosis ileitis presenting with severe intestinal haemorrhage. J R Soc Med (1988) 0.81

Oesophageal self-bougienage. Lancet (1982) 0.80

Abnormal duodenal bile composition in patients with acalculous chronic cholecystitis. Am J Gastroenterol (1998) 0.80

Anterior lesser curve seromyotomy and posterior truncal vagotomy versus truncal vagotomy and pyloroplasty in the treatment of chronic duodenal ulcer. Br J Surg (1990) 0.80

Recent developments in the treatment of alcoholic hepatitis. QJM (2003) 0.79

Achalasia in Anderson-Fabry's disease. J R Soc Med (1984) 0.77

General practice nurses' knowledge of alcohol use and misuse: a questionnaire survey. Alcohol Alcohol (2000) 0.77

Evaluation of two simplified methods for genotyping hepatitis C virus. J Med Virol (1997) 0.77

Hepatitis G virus RNA and its relation to hepatitis C infection in adult haemophilic patients. Br J Haematol (1997) 0.77

Clustering of hepatitis B virus infection and hepatocellular carcinoma in a family. J R Soc Med (1981) 0.77

Differences in the intracellular processing of the radiolabel following the uptake of iodine-125- and technetium-99m-neogalactosyl albumin by the isolated perfused rat liver. J Nucl Med (1991) 0.76

A comparison of two methods of whole gut lavage for colonoscopy. Br J Surg (1981) 0.76

Differential excretion of leucocyte granule components in inflammatory bowel disease: implications for pathogenesis. Clin Sci (Lond) (1997) 0.76

A phase I clinical evaluation of liposome-entrapped doxorubicin (Lip-Dox) in patients with primary and metastatic hepatic malignancy. Anticancer Drugs (1992) 0.76

Liver biopsy in the diagnosis of malignancy. QJM (1995) 0.75

Controlled trial of cyclophosphamide in active chronic hepatitis. Br Med J (1979) 0.75

Bone disease after jejuno-ileal bypass for morbid obesity. Postgrad Med J (1983) 0.75

Acute leukaemia during azathioprine therapy. Postgrad Med J (1977) 0.75

Use of somatostatin in the management of pancreatic haemobilia. Postgrad Med J (1989) 0.75

Direct measurement of hepatic extraction of chenodeoxycholic acid and ursodeoxycholic acid in man. Clin Sci (Lond) (1982) 0.75

Longstanding liver cysts and obstructive jaundice. Postgrad Med J (1998) 0.75

Effects of individual taurine-conjugated bile acids on biliary lipid secretion and sucrose clearance in the unanesthetized dog. Am J Physiol (1982) 0.75

Liver biopsy with plugged needle track. Lancet (1984) 0.75

Uptake and intracellular processing of galactosyl-neoglycoalbumin by the isolated perfused rat liver. Biochem Soc Trans (1990) 0.75

Liver volume and uptake assessment using 123I-BSP tomography. Nucl Med Commun (1985) 0.75

Direct measurement of hepatic extraction of bile acids in subjects with and without liver disease. Clin Sci (Lond) (1981) 0.75

Congenital double pylorus: a case report. Br J Surg (1981) 0.75

The in-vitro mucosal conjugation of ethinyloestradiol and the bioavailability of oral contraceptive steroids in patients with treated and untreated coeliac disease. Aliment Pharmacol Ther (1992) 0.75

Modern methods of diagnosis in liver disease. J R Coll Physicians Lond (1986) 0.75

Drug policy debate is needed. BMJ (2012) 0.75

Microsomal enzymes in malnutrition. Br Med J (1977) 0.75

Bile duct measurements after ceruletide as an aid to the ultrasound diagnosis of choledocholithiasis. Gastrointest Radiol (1988) 0.75

Kinetics of galactosyl-neoglycoalbumin uptake after continuous infusion into the isolated perfused rat liver. Biochem Soc Trans (1990) 0.75

Quinone-induced DNA single strand breaks in a human colon carcinoma cell line. Carcinogenesis (1997) 0.75

Is SPECT of the spleen worthwhile in the evaluation of liver disease severity? Nucl Med Commun (1987) 0.75

Ileocolonoscopic diagnosis of coeliac disease. Endoscopy (2003) 0.75

Effects of a meal on plasma clearance of [14C]glycocholic acid and indocyanine green in man. Clin Sci (Lond) (1981) 0.75

Reduction in doxorubicin toxicity following liposomal delivery. Cancer Treat Rev (1987) 0.75

Retrograde cholangiopancreatography in the diagnosis of carcinoma of the pancreas. Gastrointest Endosc (1982) 0.75

Anatomical variation and percutaneous liver biopsy failure. Lancet (1987) 0.75

Mesophase formation during cholesterol gallstone dissolution in human bile: effect of bile acid composition. J Pharm Sci (1984) 0.75

Abdominal distension. Postgrad Med J (2002) 0.75

Urinary enzyme output during detoxification of chronic alcoholic patients. Alcohol Alcohol (1989) 0.75